Replies to post #3958 on Repros Therapeutics Inc (RPRX)

[exwannabe]

Y3, other high P drugs drugs

in early (and even P3) that didn't make it are probably quite common.

Can we consider Satraplatin and Vasomax examples? I suspect more experienced biotech investors could name dozens more.

And BTW, it was YOU who used the FRAUD word wrt RPRX. But I guess you would rather just thrash randomly with BS than actually read a post you respond to.